10x Genomics (TXG) Leases (2020 - 2025)
10x Genomics (TXG) has disclosed Leases for 6 consecutive years, with $60.4 million as the latest value for Q4 2025.
- Quarterly Leases rose 5.52% to $60.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $60.4 million through Dec 2025, up 5.52% year-over-year, with the annual reading at $60.4 million for FY2025, 5.52% up from the prior year.
- Leases hit $60.4 million in Q4 2025 for 10x Genomics, down from $63.6 million in the prior quarter.
- In the past five years, Leases ranged from a high of $75.7 million in Q1 2022 to a low of $54.1 million in Q2 2021.
- Historically, Leases has averaged $64.3 million across 5 years, with a median of $62.8 million in 2024.
- Biggest five-year swings in Leases: soared 35.66% in 2022 and later fell 15.91% in 2024.
- Year by year, Leases stood at $60.9 million in 2021, then grew by 14.71% to $69.9 million in 2022, then fell by 6.47% to $65.4 million in 2023, then dropped by 12.35% to $57.3 million in 2024, then rose by 5.52% to $60.4 million in 2025.
- Business Quant data shows Leases for TXG at $60.4 million in Q4 2025, $63.6 million in Q3 2025, and $62.7 million in Q2 2025.